ODI Pharma AB launched kandol., a CBD skincare product line. The products will, as an initial step, be available online at www.kandol.net to customers within the EU starting mid-September 2021. The product line initially consists of a CBD-infused facial cream, facial mask and body balm. The products contain what the Company describes as the Golden Standard of Cannabidiol (CBD) and are designed to the EU-approved definition of Cannabidiol as an antioxidant, antiseborrheic, skin conditioner and skin protector. The dermatological efficiency tests were run on the facial cream by an independent multinational company specializing in cosmetic testing on 40 test subjects following the EU regulations. Test results have confirmed kandol. as one of the most effective skincare products and prove that the Company has found a disrupting formula that shows outstanding effects. Among other things, the product improves the appearance of the skin and compared with the same type of products used in the past, the tested product was assessed as better than (57%) or comparable with (40%) the best products the test subjects had ever tested before, meaning 97% of test subjects found ODI Pharma's product better or comparable. Tested effects were amongst others purifying pores, reducing appearance of wrinkles, improving skin condition, giving healthy look, skin smoothening, nourishing, protecting from drying and leaving the skin moisturized improving redness, reducing signs of fatigue and accelerate the disappearance of blemishes.